Longevity Research Peptides – True Peptide Labs

Cartalax

Officiallyleoa — Mon, 27 Jul 2026 20:51:34 +0000

Cartalax (Ala-Glu-Asp, AED tripeptide) is a synthetic short-peptide bioregulator. It has been characterized in chondrocyte cell-culture, cartilage-tissue explant, and connective-tissue age-related research contexts within that laboratory's broader peptidergic regulation and geroprotection literature. Chemical identity: H-Ala-Glu-Asp-OH (single-letter sequence AED); molecular formula C₁₂H₁₉N₃O₈; molecular weight ~333.3 g/mol.

The post Cartalax first appeared on True Peptide Labs.

5-AMINO-1MQ – 50mg

Officiallyleoa — Mon, 06 Jul 2026 22:56:12 +0000

5-Amino-1MQ — also written as 5-Amino 1MQ, and by its full chemical name 5-amino-1-methylquinolinium — is a small-molecule quinolinium-salt research compound. It consists of a methylquinolinium heteroaromatic cation bearing an amino substituent at the 5-position and a methyl group at the ring nitrogen, and is typically supplied as the iodide salt. The compound has a cation molecular weight of approximately 159.21 g/mol (matching the [M]⁺ ion observed at m/z 159.000 on the lot LC-MS confirmation) and, as the iodide salt, an approximate salt-form molecular weight of 286.11 g/mol.

This product is supplied as an orange lyophilized powder — the characteristic color arises from the extended aromatic chromophore of the methylquinolinium ring system. The lot referenced here (5AMI-015-TPL) has a documented purity of 99.77% by HPLC with UV detection, with identity confirmed by LC-MS. Labeled vial size is 10 mg; net content per vial per the COA is 11.28 mg. Third-party characterization was performed by Freedom Diagnostics (USA). The product is intended exclusively for in-vitro laboratory research and analytical applications.

In the biochemistry research literature, 5-Amino-1MQ is characterized as a small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT), a cytosolic methyltransferase that catalyzes the transfer of a methyl group from S-adenosyl methionine (SAM) to nicotinamide.

The post 5-AMINO-1MQ – 50mg first appeared on True Peptide Labs.

Epithanlon 50mg

Officiallyleoa — Tue, 19 Aug 2025 06:14:43 +0000

The post Epithanlon 50mg first appeared on True Peptide Labs.

MOTS-C 40mg

Officiallyleoa — Wed, 13 Aug 2025 12:04:35 +0000

The post MOTS-C 40mg first appeared on True Peptide Labs.

PINEALON-10mg

Officiallyleoa — Wed, 13 Aug 2025 07:15:29 +0000

The post PINEALON-10mg first appeared on True Peptide Labs.

EPITHALON 10mg

Officiallyleoa — Fri, 08 Aug 2025 20:15:52 +0000

The post EPITHALON 10mg first appeared on True Peptide Labs.

5 Amino 1MQ

Officiallyleoa — Fri, 08 Aug 2025 03:54:58 +0000

The post 5 Amino 1MQ first appeared on True Peptide Labs.

NAD+ 500mg

Officiallyleoa — Tue, 15 Jul 2025 17:16:18 +0000

NAD+ — full chemical name Nicotinamide Adenine Dinucleotide — is an endogenous pyridine dinucleotide coenzyme with an approximate molecular weight of 663.43 g/mol and CAS number 53-84-9 (free acid form). Structurally, NAD+ consists of two nucleotides joined through a pyrophosphate bridge: an adenosine 5′-monophosphate (AMP) moiety and a nicotinamide mononucleotide (NMN) moiety. This product is supplied as the oxidized form (NAD⁺); the reduced counterpart NADH is a chemically distinct compound not covered by this SKU.

The lot referenced here (NAD5-032-TPL) is supplied as a white lyophilized powder with a documented purity of 99.57% by HPLC with UV detection, and identity confirmed by LC-MS through convergent observation across two charge states — [M+H]⁺ at m/z 663.700 and [M+2H]²⁺ at m/z 332.600. Labeled vial size is 500 mg; net content per vial per the COA is 521.11 mg. Third-party characterization was performed by Freedom Diagnostics (USA). The product is intended exclusively for in-vitro laboratory research and analytical applications.

In the biochemistry research literature, NAD+ is described as a coenzyme that participates in oxidation-reduction reactions as an electron acceptor, alternating between its oxidized (NAD⁺) and reduced (NADH) forms.

The post NAD+ 500mg first appeared on True Peptide Labs.

MOTS-C 10mg

Officiallyleoa — Tue, 15 Jul 2025 17:15:31 +0000

MOTS-c — full name “Mitochondrial Open reading frame of the Twelve S rRNA – c” — is a synthetic 16-amino-acid peptide corresponding to a mitochondrial-derived peptide (MDP) that is encoded within a short open reading frame in the human mitochondrial 12S ribosomal RNA gene. MDPs are peptides whose coding sequences are found within mitochondrial DNA rather than in nuclear DNA, and MOTS-c is among the earliest such peptides to be characterized. The peptide was first identified and characterized in the laboratory of Pinchas Cohen at the USC Leonard Davis School of Gerontology.

The peptide has a molecular weight of approximately 2174.5 g/mol and CAS number 1627580-64-6, with the one-letter sequence MRWQEMGYIFYPRKLR. On the lot referenced here (MOTS-210-TPL), identity is confirmed by LC-MS through convergent observation across four charge states — [M+5H]⁵⁺ at m/z 435.900, [M+4H]⁴⁺ at 544.600, [M+3H]³⁺ at 725.700, and [M+2H]²⁺ at 1088.500 — each back-calculating to the expected ~2174.5 Da mass. Documented purity by HPLC with UV detection is 99.45%. Third-party characterization was performed by Freedom Diagnostics (USA).

This product is supplied as a white lyophilized powder at 10 mg labeled size (11.14 mg net content per vial per the COA), synthesized by solid-phase peptide synthesis (SPPS). It is intended exclusively for in-vitro laboratory research and analytical applications.

In the research literature, MOTS-c is referenced as a synthetic mitochondrial-derived peptide used as a reference compound in biochemistry research on the MDP class.

The post MOTS-C 10mg first appeared on True Peptide Labs.